Eye implant could restore sight in advanced AMD
NCT ID NCT04796545
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a small telescope-like implant placed inside the eye to improve vision in people with end-stage age-related macular degeneration (AMD). 76 participants aged 55 and older will receive the implant and be followed for 12 months. The goal is to see if the device safely improves both near and distance vision.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
SING IMT 3X implant (a tiny telescope device surgically placed in the eye)
What this could lead to
If it works, this implant could help people with advanced AMD see better up close and far away, potentially improving daily life.
What could go wrong
This is a small, early-stage study with only 76 people. The implant requires eye surgery, which carries risks like infection or reduced corneal cells. It may not work for everyone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AGE-RELATED MACULAR DEGENERATION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Augenklinik Städtisches Klinikum Karlsruhe
TERMINATEDKarlsruhe, Germany
-
CHRU de Strasbourg
RECRUITINGStrasbourg, France
Contact
-
Centre d'Ophtalmologie Paradis-Monticelli
RECRUITINGMarseille, France
Contact
-
Fondazione Policlinico Universitario Agostino Gemelli
RECRUITINGRoma, Italy
Contact
-
Hospital Universitario La Luz - Quirónsalud
RECRUITINGMadrid, Spain
Contact
-
Hélios Ophtalmologie, Saint-Jean-de-Luz
RECRUITINGSaint-Jean-de-Luz, France
Contact
-
Institut OMIQ
RECRUITINGBarcelona, Spain
Contact
-
Mater Misericordiae University Hospital
RECRUITINGDublin, Ireland
Contact
-
Royal Victoria Hospital Belfast Health & Social Care Trust
RECRUITINGBelfast, United Kingdom
Contact
-
UZ Brussel
RECRUITINGBrussels, Belgium
Contact
-
Università degli Studi di Napoli Federico II
RECRUITINGNaples, Italy
Contact
-
Universitätsklinikum Münster Klinik für Augenheilkunde
RECRUITINGMünster, Germany
Contact
-
VISSUM
RECRUITINGAlicante, Spain
Contact